Stock CLCS CELL SOURCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Cell Source, Inc.

Equities

CLCS

US15114L1044

Market Closed - OTC Markets
Other stock markets
 17:54:58 09/05/2024 BST 		5-day change 1st Jan Change
0.0008 USD +300.00% Intraday chart for Cell Source, Inc. 0.00% -99.83%
03-22 Cell Source, Inc. announced that it has received $4.76017 million in funding CI
2023 Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CELL SOURCE, INC.
Bio Therapeutic Drugs
+300.00%0.00%-99.83%+100.00%-99.88% 32.82K - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CLCS Stock
  4. Charts Cell Source, Inc.
  5. Comparison Chart